-+ 0.00%
-+ 0.00%
-+ 0.00%

Prostatype Genomics Expects to Submit Additional Medicare Review Information Nov. 23-29

PUBT·11/19/2026 12:04:02
Diffusion vocale
Prostatype Genomics Expects to Submit Additional Medicare Review Information Nov. 23-29
  • Prostatype Genomics expects to submit supplementary information for its U.S. Medicare coverage review during November 23-29, 2026.
  • Medicare's MolDX working group requested additional information on one previously discussed issue concerning the Prostatype prostate cancer test.
  • Timing of a final coverage decision remains uncertain.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prostatype Genomics AB published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.